v3.26.1
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenues $ 218,250 $ 163,353 $ 374,663 $ 308,887
Expenses:        
Cost of product sales 3,840 2,798 9,217 7,366
Acquired in-process research and development 0 0 697,761 0
Research and development 51,969 43,386 112,288 80,656
Selling, general and administrative 63,976 87,383 158,530 169,852
Total operating expenses 119,785 133,567 977,796 257,874
Income (loss) from operations 98,465 29,786 (603,133) 51,013
Other income (expense):        
Interest income 2,434 2,516 4,690 5,540
Interest expense (21,712) (21,582) (41,491) (45,076)
Foreign currency gains (losses), net 27 (63) (198) (62)
Loss on extinguishment of debt 0 (4,171) 0 (4,171)
Other income (expense), net 260 0 (1,202) 0
Total other expense, net (18,991) (23,300) (38,201) (43,769)
Income (loss) before income taxes 79,474 6,486 (641,334) 7,244
Income tax expense 1,079 1,401 2,083 2,127
Net income (loss) 78,395 5,085 (643,417) 5,117
Other comprehensive (loss) income:        
Foreign currency translation adjustment (27) 702 (89) 1,068
Unrealized loss on available for sale investments (133) (188) (477) (343)
Total other comprehensive (loss) income (160) 514 (566) 725
Net comprehensive income (loss) $ 78,235 $ 5,599 $ (643,983) $ 5,842
Net income (loss) per common share, basic (in usd per share) $ 0.31 $ 0.02 $ (2.59) $ 0.02
Weighted average shares of common stock outstanding, basic (in shares) 254,481 209,519 248,403 209,203
Net income (loss) per common share, diluted (in usd per share) $ 0.30 $ 0.02 $ (2.59) $ 0.02
Weighted average shares of common stock outstanding, diluted (in shares) 265,165 219,886 248,403 217,574
Product sales, net        
Revenues:        
Total revenues $ 157,513 $ 162,430 $ 308,914 $ 306,217
License and other revenues        
Revenues:        
Total revenues $ 60,737 $ 923 $ 65,749 $ 2,670